This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Clorox (CLX) Earnings Surpass Estimates in Q2, Sales Miss
by Zacks Equity Research
Clorox (CLX) retains forecasts for fiscal 2019, which should benefit from ongoing cost-savings plans.
3 Dividend Growth ETFs & Stocks to Counter Looming Volatility
by Sanghamitra Saha
Weighed down by trade tensions, global growth worries and U.S. government shutdown? Play these dividend growth ETFs and stocks.
Procter & Gamble (PG) Stock Moves -0.09%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $93.52, moving -0.09% from the previous trading session.
Friday Rally Helps the Markets Recover Earlier Weekly Losses
by David Borun
Positive earnings data and an end to the government shutdown help keep the 2019 rally gooing
Colgate (CL) Q4 Earnings Beat, Soft 2019 View Hurts Stock
by Zacks Equity Research
Colgate's (CL) fourth-quarter 2018 earnings and sales beat estimates on solid organic sales, and improved pricing. However, the company issues a soft earnings view for 2019.
Dow 30 Stock Roundup: UTX, TRV, PG, JNJ Earnings Impress, IBM Revenues Decline Y/Y
by Swarup Gupta
The index traversed an eventful, yet holiday-shortened week.
Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie
by Zacks Equity Research
Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie
Stock Market News for Jan 24, 2019
by Zacks Equity Research
Wall Street recovered some of its previous day's losses on Wednesday buoyed by strong fourth quarter earnings results of several major companies
TXN vs. INTC Ahead of Earnings and Reports from IBM, UTX, & More
by Ryan McQueeney
Ryan McQueeney recaps earnings results from IBM, United Technologies, Procter & Gamble, and Comcast. Later, he previews upcoming reports from chip giants Texas Instruments and Intel.
Q4 2018 Earnings in Full Swing
by Zacks Equity Research
Q4 2018 Earnings in Full Swing
Q4 Earnings Roundup: PG, CMCSA, KMB & More
by Mark Vickery
Q4 earnings season continues to shift to a higher gear, and this morning we've got plenty more Q4 reports to tuck into.
Procter & Gamble (PG) Rises on Q2 Earnings Beat, Ups View
by Zacks Equity Research
Organic sales growth across most segments aids Procter & Gamble's (PG) earnings and sales in second-quarter fiscal 2019. The company raises organic sales view for fiscal 2019.
Procter & Gamble (PG) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 3.31% and 1.43%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Blue Chips IBM and Proctor and Gamble Rally on Earnings
by David Borun
Investors are delighted with improved guidance as well as solid earnings
Can Clorox's Strategic Growth Efforts Offset Margin Issues?
by Zacks Equity Research
Clorox (CLX) witnesses strained margins due to higher costs. Nevertheless, its 2020 Strategy and Go Lean initiative to rebuild margins are encouraging.
Why Earnings Season Could Be Great for Procter & Gamble (PG)
by Zacks Equity Research
Procter & Gamble (PG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Procter & Gamble (PG) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Procter & Gamble (PG) have what it takes? Let's find out.
3 Soaps and Cleaning Materials Stocks Set to Beat Q4 Earnings
by Zacks Equity Research
The Soaps and Cleaning Materials industry remains lucrative, backed by product innovation, and cost-saving and restructuring efforts despite soft sales and margins woes.
Key Takeaways from Q4 Earnings Results Thus Far
by Sheraz Mian
First, growth is decelerating. This isn't a surprise, as we knew already that Q4 growth would be materially below the pace set in the first three quarters of the year.
Will Procter & Gamble (PG) Retain Earnings Beat Trend in Q2?
by Zacks Equity Research
Procter & Gamble's (PG) strategic efforts such as product improvement and cost-saving plans are impressive. However, commodity cost inflation and adverse currency remain concerns.
The Zacks Analyst Blog Highlights: Procter & Gamble, NVIDIA, Bristol-Myers, Deere and Ecolab
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, NVIDIA, Bristol-Myers, Deere and Ecolab
Procter & Gamble (PG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Analyst Reports for Procter & Gamble, NVIDIA & Bristol-Myers
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), NVIDIA (NVDA) and Bristol-Myers (BMY).
Procter & Gamble (PG) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $91.99, moving +0.92% from the previous trading session.
A Look at Dow ETF Ahead of Q4 Earnings
by Sweta Killa
Let's delve into the Q4 earnings picture that will likely set up the movement of Dow Jones ETF in the coming days.